Equity
4BodyEvolution paid out €833 in dividends. That is 31% of the 2025 profit.
4BodyEvolution paid out €833 in dividends. That is 31% of the 2025 profit.
The micro format states no turnover.
Of this, €52,972 falls due within a year.
Green is investment, beige is depreciation. Machinery stands 96.1% higher than in 2024.
In 2025, 13 people joined and 12 left.
Lower solvency than 89% of companies in human health. Sector median 63.0% · 20,774 companies.
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 11% of them on solvency, 24% on liquidity, 15% on profitability and 73% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 2,135 companies had the same profile as 4BodyEvolution has now. Each dot stands for 6 companies, two years later.
Another 0.4% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of 4BodyEvolution itself is lower: 0.1% within 12 months. It rests on far more data about 4BodyEvolution than the profile alone.
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,135 companies, not a prediction for 4BodyEvolution. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is insufficient, with a current ratio of 0.44 (0.19 in 2024), below 1. Short-term debt is 36.4% and cash 14% of total assets. 94.7% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 4 accounts on average 36 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| 4BodyEvolution Villers-le-Bouillet | €145,355 | €73,413 | 5.3% | - |
| ERODENT Hannut | €125,290 | €64,394 | 28.1% | - |
| BY AUDIO Brussels | €152,465 | €68,525 | 12.2% | - |
| Mondhygiëniste Cato Willemaers Tongeren-Borgloon | €172,449 | €79,307 | 1.7% | - |
| ORAL HEALTH CARE Lievegem | €176,430 | €74,946 | 89.5% | - |
| BOUDRU SOPHIE PODOLOGUE Dalhem | €164,262 | €56,199 | 41.3% | - |
| BUCODENTAL Herstal | €169,902 | €107,668 | 89.7% | - |
These companies have the same main activity as 4BodyEvolution: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €125,000 and €176,000, founded between 2022 and 2023.
4BodyEvolution files the micro format. That format states no turnover. The gross margin rose from €11,017 in 2022 to €73,413 in 2025.
The balance sheet grew most from 2024 to 2025 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €200,000. Estimated: probably between €130,000 and €300,000.
Higher than 10% of 20,774 companies in 2025.
Higher than 5% of 20,348 companies in 2025.
Higher than 10% of 20,630 companies in 2025.
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: middle half · Working capital: bottom quarter
Staff costs divided by the average number of full-time equivalents.
In 2025, 13 people joined and 12 left.
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
145,355 | 85,790 | 72,451 | 91,594 | |
21/28 |
122,123 | 79,245 | 66,387 | 82,872 | |
22/27 |
122,123 | 79,245 | 66,387 | 82,872 | |
22 |
623 | 1,123 | 1,623 | 2,123 | |
23 |
74,981 | 38,237 | 48,679 | 62,547 | |
24 |
2,526 | 2,535 | 375 | 675 | |
26 |
43,993 | 37,350 | 15,711 | 17,527 | |
29/58 |
23,232 | 6,545 | 6,064 | 8,721 | |
40/41 |
1,385 | 347 | 2,225 | 1,959 | |
40 |
553 | 346 | 2,214 | 525 | |
41 |
832 | 2 | 11 | 1,434 | |
54/58 |
20,349 | 4,084 | 3,087 | 6,487 | |
490/1 |
1,498 | 2,113 | 752 | 276 | |
| Balance sheet: equity and liabilities | |||||
10/49 |
145,355 | 85,790 | 72,451 | 91,594 | |
10/15 |
7,643 | 5,810 | 4,531 | 3,190 | |
10/11 |
5,000 | 5,000 | 5,000 | 5,000 | |
14 |
2,643 | 810 | -469 | -1,810 | |
17/49 |
137,713 | 79,980 | 67,920 | 88,404 | |
17 |
84,740 | 45,031 | 33,038 | 44,806 | |
170/4 |
84,740 | 45,031 | 33,038 | 44,806 | |
42/48 |
52,972 | 34,949 | 34,882 | 43,597 | |
42 |
21,664 | 18,715 | 11,768 | 11,449 | |
44 |
6,070 | 4,360 | 1,389 | 2,883 | |
440/4 |
6,070 | 4,360 | 1,389 | 2,883 | |
45 |
13,592 | 5,258 | 3,375 | 3,500 | |
450/3 |
3,589 | 2,070 | 2,416 | 1,800 | |
454/9 |
10,002 | 3,189 | 959 | 1,700 | |
47/48 |
11,647 | 6,615 | 18,351 | 25,765 | |
| Income statement | |||||
9900 |
73,413 | 48,955 | 43,854 | 11,017 | |
62 |
33,924 | 23,836 | 23,050 | 150 | |
630 |
27,511 | 19,849 | 17,438 | 11,445 | |
640/8 |
2,658 | 787 | 315 | 344 | |
9901 |
9,320 | 4,484 | 3,051 | -921 | |
75/76B |
17 | 10 | 23 | - | |
75 |
17 | 10 | 23 | - | |
65/66B |
5,357 | 2,402 | 1,733 | 889 | |
65 |
5,357 | 2,402 | 1,733 | 889 | |
9903 |
3,979 | 2,092 | 1,341 | -1,810 | |
67/77 |
1,313 | 813 | - | - | |
9904 |
2,666 | 1,279 | 1,341 | -1,810 | |
9905 |
2,666 | 1,279 | 1,341 | -1,810 | |
| Appropriation of the result | |||||
9906 |
3,476 | 810 | -469 | -1,810 | |
14P |
810 | -469 | -1,810 | - | |
694/7 |
833 | - | - | - | |
694 |
833 | - | - | - | |
| Social balance sheet | |||||
9087 |
2.2 | - | 1.3 | - | |
Hours worked1013 |
1,279 | - | 1,383 | - | |
| Document | |||||
The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 06-07-2026.
| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| 36,831 | 24,332 | 20,489 | 10,523 | ||
| 30,177 | 21,128 | 18,779 | 9,635 | ||
| 74,812 | 32,707 | 953 | 94,317 | ||
| 16,265 | 997 | -3,400 | - | ||
| -29,740 | -28,404 | -28,818 | -34,876 | ||
| 5.3% | 6.8% | 6.3% | 3.5% | ||
| 0.44 | 0.19 | 0.17 | 0.20 | ||
| 18.02 | 13.77 | 14.99 | 27.71 | ||
| 34.9% | 22.0% | 29.6% | -56.7% | ||
| 1.8% | 1.5% | 1.9% | -2.0% | ||
| 6.87 | 10.13 | 11.82 | 11.84 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 31-12-2025 | 31-12-2023 |
|---|---|---|
| Employees at the balance-sheet date | 2 | 2 |
| part-time | 2 | 2 |
| in full-time equivalents | 0.7 | 0.7 |
| 0.9 | 0.7 | |
| On a permanent contract | 1 | 1 |
| Joined | 13 | 3 |
| Left | 12 | 1 |
Source: social balance sheet in the 2023 to 2025 annual accounts
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | €74,812 | €32,707 | €953 | €94,317 |
| €27,511 | €19,849 | €17,438 | €11,445 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is 108% higher than in 2024 and the highest since 2022. It is the third rise in a row.
Debt's share of the balance-sheet total rises from 93.2% to 94.7%. Equity and debt are higher.
4BodyEvolution has no parent and no holdings in its annual accounts. 4BodyEvolution shares no director with another company.
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
| Establishment | Since | Unit number |
|---|---|---|
| Rue Isidore Chabot 19 registered office 4530 Villers-le-Bouillet | 01-07-2022 | 2.332.709.349 |
| Rue Bourie 19 5300 Andenne | 01-05-2024 | 2.366.778.521 |
| Quai de Lorraine 37 4540 Amay | 27-05-2025 | 2.373.998.091 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 61004A0672/00T000 | 9,037 m² | - | - |
| 61074C0026/00F000 | 1,582 m² | 1 · 86 m² | 7.2 m · 1 |
If something looks wrong or is missing, please tell us.